Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2Gastrointestinal 1

Conditions

Colorectal Neoplasms 3Breast Neoplasms 2Risk Reduction Behavior 1Patient Preference 1Patient Acceptance of Health Care 1Health Behavior 1Diabetes Mellitus 1Coronary Disease 1Behavior 1

Interventions

Trastuzumab 350Paclitaxel 334Cyclophosphamide 315Docetaxel 291Capecitabine 181Doxorubicin 180Letrozole 166Tamoxifen 145Bevacizumab 124Fulvestrant 118Carboplatin 118exemestane 111Lapatinib 111Anastrozole 111Radiotherapy 105Epirubicin 104Gemcitabine 97palbociclib 84Exercise 78Vinorelbine 77Fluorouracil 77Surveys and Questionnaires 71pertuzumab 67Filgrastim 64Albumin-Bound Paclitaxel 64eribulin 55Magnetic Resonance Spectroscopy 55Everolimus 52Blood Specimen Collection 51Zoledronic Acid 50

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Breast Neoplasms × Risk Assessment × Clear all
NCT05834933 2023-08-03

NBCRS

University of Ibadan

Phase NA Completed
719 enrolled
Breast

Behavior, Breast Neoplasms, Patient Acceptance of Health Care, Health Behavior, Risk Reduction Behavior

NCT01468675 2017-04-28

Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary Care

Brigham and Women's Hospital

Phase NA Completed
6,075 enrolled 5 charts
BreastGastrointestinal

Breast Neoplasms, Coronary Disease, Diabetes Mellitus, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡